Legal & General Group
FSTX

Legal & General Group’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Legal & General Group’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-579
Closed -$9K – 3447
2019
Q2 		$9K Hold
579
– – ﹤0.01% 3384
2019
Q1 		$24K Hold
579
– – ﹤0.01% 3036
2018
Q4 		$24K Hold
579
– – ﹤0.01% 3012
2018
Q3 		$28K Buy
579
+167
+41% +$8.36K ﹤0.01% 3068
2018
Q2 		$20K Buy
+412
New +$22.9K ﹤0.01% 3192

Other funds holding FSTX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TA
Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return

Legal & General Group's FSTX Position: Q3 2019 in Review

Legal & General Group sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q3 2019, closing a stake of 579 shares — an estimated $9K sold.

Legal & General Group first reported a position in FSTX in Q2 2018 and held it in 5 quarters. The position peaked at $28K in Q3 2018. 40 funds tracked by Wall St. Rank hold FSTX as of Q3 2019.

  • Legal & General Group reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Legal & General Group sold 579 F-star Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $9K.
  • Legal & General Group first reported a position in F-star Therapeutics, Inc. Common Stock in Q2 2018 and held it in 5 quarters.
  • Legal & General Group's F-star Therapeutics, Inc. Common Stock position peaked at $28K in Q3 2018.
  • 40 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q3 2019.

Based on Legal & General Group's 13F filing for Q3 2019, filed 13 Nov 2019.